Latest

magic mushrooms

Featured Neuroscience Open Neuroscience Articles Psychology

·April 17, 2020·3 min read

Psychedelic compound from magic mushrooms produced in yeast

Psilocybin can be produced de novo in yeast. The findings could help with the development of drugs that utilize the psychedelic compound to treat depression and other mental health disorders.

Featured Neuroscience Psychology

·August 19, 2018·5 min read

The Real Promise of LSD, Mushrooms and MDMA for Medical Science

Researchers explore why using hallucinogens to treat an array of mental health disorders is becoming more popular.

Featured Neuroscience Open Neuroscience Articles

·February 27, 2018·3 min read

Why Are Some Mushrooms “Magic”?

Researchers investigate the evolutionary development of psilocybin in some mushrooms. They conclude mushrooms may have evolved to be hallucinogenic to lower the odds of being eaten by insects.

Featured Neuroscience Open Neuroscience Articles Psychology

·January 26, 2018·5 min read

Magic Mushrooms May Alter How You Feel About Nature (and Politics)

Months after receiving psilocybin treatments for depression, patients report feeling more connected with nature and experience a shift away from authoritarian political views, researchers report.

Image shows a trippy psychedelic drawing.

Featured Psychology

·October 18, 2017·4 min read

Psychedelic Drugs Could Reduce Criminal Behavior

A new study reports people who have used a classic psychedelic are significantly less likely to commit a crime or indulge in criminal behavior. However, use of other controlled substances is linked to an increased risk of criminal behavior, researchers report.

Featured Open Neuroscience Articles Psychology

·October 13, 2017·6 min read

Magic Mushrooms May ‘Reset’ Brains of Depressed Patients

A new study adds to growing evidence supporting the benefits of psychedelics to treat mental illnesses. Researchers report psilocybin, the psychoactive compound in magic mushrooms, is effective in reducing symptoms for people with treatment resistant depression. The study reveals the compound resets the activity of a brain network associated with depression, helping to improve symptoms in patients for up to 5 weeks following treatment.

Image shows a drawing of magic mushrooms.

Featured Open Neuroscience Articles Psychology

·December 30, 2016·6 min read

Researchers Urge Caution Around Psilocybin Use

While many people reported a 'bad trip' when taking psilocybin containing mushrooms, most report experiencing meaningful and worthwhile experiences while under the influence.

Brain Cancer Featured Neuroscience Open Neuroscience Articles Psychology

·December 1, 2016·4 min read

Hallucinogenic Psilocybin Offers Relief For Cancer Related Depression and Anxiety

According to researchers, a single large dose if psilocybin, the active hallucinogenic compound found in magic mushrooms, helped provide relief for people suffering from cancer related depression and anxiety for up to six months.

Image shows a Psilocybe “cyanofriscosa” mushroom.

Featured Open Neuroscience Articles Psychology

·May 17, 2016·6 min read

Magic Mushroom Compound May Provide New Avenues for Antidepressant Research

In a new study, researchers report on the potential for using psilocybin, a hallucinogenic compound derived from magic mushrooms, for treating patients with treatment resistant depression.

Image shows Psilocybe allenii mushrooms.

Brain Cancer Featured Neuroscience Psychology

·December 10, 2015·1 min read

Magic Mushroom Component Reduces Depression and Anxiety in Cancer Patients

Study suggests that a single dose of psilocybin, the active ingredient of magic mushrooms, may be enough to produce a lasting decrease in depression and anxiety for cancer patients.